Stockley's Drug Interactions, edited by Claire L Preston, remains the world's most comprehensive and authoritative international reference book on drug interactions. Based upon thousands of published papers and reports this eleventh edition:

Covers interactions between therapeutic drugs, proprietary medicines, herbal medicines, foods, drinks, and drugs of abuse
Contains in-depth yet concise monographs in an easy-to-read format
Provides comprehensive details of the clinical evidence for the interactions under discussion, an assessment of their clinical importance, and clear guidance on managing the interaction in practice
Has a brief summary of the interaction in each monograph perfect for the busy healthcare professional
Is fully referenced throughout
Contains almost 4500 monographs
Is global in coverage inclusion of drugs used worldwide

New in the 11th edition:
Over 350 new monographs added
Many existing monographs have been reviewed, revalidated, and updated
A comprehensive update and restructure of the chapter on Antidiabetic drugs, in-line with published literature
Addition of new advice regarding the concurrent use of aliskiren, ACE inhibitors, and angiotensin-II receptor antagonists
An updated list of drugs that have a risk of prolonging the QT interval
The addition of new drugs, including apixaban, apremilast, dolutegravir, lomitapide, mirabegron, the NS5A inhibitors (daclatasvir, ledipasvir, ombitasvir), the NS5B inhibitors (dasabuvir, sofosbuvir), the sodium-glucose co-transporter-2 inhibitors (canagliflozin, dapagliflozin, empagliflozin), and telavancin